264 related articles for article (PubMed ID: 28357602)
1. The clinical importance of the thyroid nodules during anti-tumor necrosis factor therapy in patients with axial spondyloarthritis.
Terlemez R; Akgün K; Palamar D; Boz S; Sarı H
Clin Rheumatol; 2017 May; 36(5):1071-1076. PubMed ID: 28357602
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNFα agents and methotrexate in spondyloarthritis related uveitis in a Chinese population.
Lian F; Zhou J; Wei C; Wang Y; Xu H; Liang L; Yang X
Clin Rheumatol; 2015 Nov; 34(11):1913-20. PubMed ID: 26070537
[TBL] [Abstract][Full Text] [Related]
3. Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study.
Berghen N; Teuwen LA; Westhovens R; Verschueren P
Clin Rheumatol; 2015 Oct; 34(10):1687-95. PubMed ID: 26219489
[TBL] [Abstract][Full Text] [Related]
4. Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study.
Durnez A; Paternotte S; Fechtenbaum J; Landewé RB; Dougados M; Roux C; Briot K
J Rheumatol; 2013 Oct; 40(10):1712-8. PubMed ID: 23950191
[TBL] [Abstract][Full Text] [Related]
5. Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France).
Soubrier M; Pereira B; Fan A; Frayssac T; Couderc M; Malochet-Guinamand S; Mathieu S; Tatar Z; Tournadre A; Dubost JJ
Int J Rheum Dis; 2018 Nov; 21(11):1986-1992. PubMed ID: 30168265
[TBL] [Abstract][Full Text] [Related]
6. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology.
Lin JD; Chao TC; Huang BY; Chen ST; Chang HY; Hsueh C
Thyroid; 2005 Jul; 15(7):708-17. PubMed ID: 16053388
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study.
Lubrano E; Massimo Perrotta F; Manara M; D'Angelo S; Addimanda O; Ramonda R; Punzi L; Olivieri I; Salvarani C; Marchesoni A
J Rheumatol; 2016 Aug; 43(8):1541-6. PubMed ID: 27252428
[TBL] [Abstract][Full Text] [Related]
8. Body weight, gender and response to TNF-α blockers in axial spondyloarthritis.
Gremese E; Bernardi S; Bonazza S; Nowik M; Peluso G; Massara A; Tolusso B; Messuti L; Miceli MC; Zoli A; Trotta F; Govoni M; Ferraccioli G
Rheumatology (Oxford); 2014 May; 53(5):875-81. PubMed ID: 24407233
[TBL] [Abstract][Full Text] [Related]
9. Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.
Lindström U; Glintborg B; Di Giuseppe D; Nordström D; Aarrestad Provan S; Gudbjornsson B; Askling J; Lund Hetland M; Aaltonen K; Krogh NS; Geirsson AJ; Jacobsson LTH
RMD Open; 2019; 5(2):e001079. PubMed ID: 31749988
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant Thyroid Findings in Patients With End-Stage Renal Disease.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Özgün G; Kazancı S; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):67-70. PubMed ID: 27805516
[TBL] [Abstract][Full Text] [Related]
11. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
[TBL] [Abstract][Full Text] [Related]
12. Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.
Hmamouchi I; Roux C; Paternotte S; Kolta S; Dougados M; Briot K
J Rheumatol; 2014 Jun; 41(6):1112-7. PubMed ID: 24737911
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients.
Pilli T; Cantara S; Marzocchi C; Cardinale S; Santini C; Cevenini G; Pacini F
Thyroid; 2017 Aug; 27(8):1053-1057. PubMed ID: 28605303
[TBL] [Abstract][Full Text] [Related]
15. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
16. McGill Thyroid Nodule Score in Differentiating Benign and Malignant Pediatric Thyroid Nodules: A Pilot Study.
Canfarotta M; Moote D; Finck C; Riba-Wolman R; Thaker S; Lerer TJ; Payne RJ; Cote V
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):589-595. PubMed ID: 28653562
[TBL] [Abstract][Full Text] [Related]
17. Pediatric thyroid nodules: insights in management.
Lugo-Vicente H; Ortíz VN
Bol Asoc Med P R; 1998; 90(4-6):74-8. PubMed ID: 9866271
[TBL] [Abstract][Full Text] [Related]
18. Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis.
Vincent FB; Pavy S; Krzysiek R; Lequerré T; Sellam J; Taoufik Y; Mariette X; Miceli-Richard C
Joint Bone Spine; 2016 Oct; 83(5):595-7. PubMed ID: 27066773
[No Abstract] [Full Text] [Related]
19. Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis.
Favalli EG; Selmi C; Becciolini A; Biggioggero M; Ariani A; Santilli D; Fusaro E; Parisi S; Massarotti M; Marchesoni A; Meroni PL
Arthritis Care Res (Hoboken); 2017 Jun; 69(6):867-874. PubMed ID: 27696735
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
